https://orcid.org/0000-0001-8193-999X
Figures & data
Figure 1. Plain language summary infographic.
Figure 2. Importance of vaccinating for HepA or HepB based on the ACIP recommendations in the overall sample. ACIP: Advisory Committee on Immunization Practices; CDC: Centers for Disease Control and Prevention; HepA: Hepatitis A; HepB: Hepatitis B. HCPs were asked how important it was to vaccinate the individuals within the listed patient populations for HepA based on the ACIP recommendations.
Figure 3. Proportion of HCPs who report recommending a HepA or HepB vaccination to patients at risk (all HCPs, N = 400)*. HCP: healthcare provider; HepA: Hepatitis A; HepB: Hepatitis B; MSM: men who have sex with men. HCPs were asked if they recommended a HepB vaccine to specified patient populations (aged ≥ 19 years). *Percentages were calculated based on the total number of HCPs who reported having experience treating each patient population.
Figure 4. Reasons for not recommending HepA vaccines to patients at risk (All HCPs, N = 400). HCP: healthcare provider; HepA: Hepatitis A; HepB: Hepatitis B; MSM: men who have sex with men.
Figure 5. Reasons for not recommending HepB vaccines to patients at risk (All HCPs, N = 400).
Supplemental Material
Download MS Word (171.8 KB)Data availability statement
GSK makes available the anonymized individual participant data and associated documents from interventional clinical studies that evaluate medicines, upon approval of proposals submitted to www.clinicalstudydatarequest.com. To access data for other types of GSK sponsored research, for study documents without patient-level data and for clinical studies not listed, please submit an enquiry via the website.